Guatemala vs Guinea-Bissau: The number of people with susceptibility test result for rifampicin
Guatemala
2,022
in 2021
Guinea-Bissau
1,934
in 2021
Guatemala rank
46th
Guinea-Bissau rank
48th
The number of people with susceptibility test result for rifampicin over time
- Guatemala
- Guinea-Bissau
How they compare
Guatemala currently reports 2,022 against 1,934 in Guinea-Bissau, a difference of 88.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Guatemala ahead.
Guatemala ranks 46th and Guinea-Bissau ranks 48th of 155 countries.
Across the 2 decades both report, Guatemala averaged higher in 1 and Guinea-Bissau in 1.
Head to head by decade
| Decade | Guatemala | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,126 | 20.67 | 1,105 | Guatemala |
| 2020s | 1,352 | 1,573 | 221 | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guatemala or Guinea-Bissau?
- Guatemala, at 2,022 against 1,934 in Guinea-Bissau as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guatemala and Guinea-Bissau?
- 88, with Guatemala ahead.
- How many years of comparable data are there for Guatemala and Guinea-Bissau?
- 5 years are reported by both, from 2017 to 2021.
- How do Guatemala and Guinea-Bissau rank globally for the number of people with susceptibility test result for rifampicin?
- Guatemala ranks 46th and Guinea-Bissau ranks 48th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.